Tennessee

No — Tennessee allows asynchronous-first care. A Tennessee-licensed provider can review your intake by secure message and, if appropriate, prescribe semaglutide without a scheduled video call, provided the standard of care is met. Your provider may request a brief video visit or additional information only if your history calls for it.

Start with Pallas's online intake, which takes under five minutes and covers your health history, weight-loss goals, and current medications. A clinician licensed in Tennessee reviews your intake — asynchronously by secure message in most cases, since Tennessee does not require a video visit — and, if a GLP-1 is clinically appropriate, sends your prescription to a US-licensed pharmacy that ships free to any Tennessee address, typically within 2–3 business days.

Yes — compounded semaglutide is available to eligible Tennessee residents through licensed telehealth. It is prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a Tennessee-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. Pallas serves Tennessee with free shipping. FDA-approved brand-name options like Wegovy^® and Zepbound^® are also available through the same intake.

Complete the same online intake used for semaglutide, noting tirzepatide as your preferred medication. A Tennessee-licensed clinician reviews your history and, if appropriate, prescribes it — either compounded tirzepatide, prepared per-patient by a US-licensed §503A pharmacy based on a documented clinical rationale, or an FDA-approved brand like Zepbound^® or Mounjaro^® (Eli Lilly), available cash-pay through the same intake. Your clinician will discuss which option fits your history; the two are not interchangeable, and choosing between them is a clinical decision.

Yes, within the limits of Tennessee's nurse practitioner scope of practice. Tennessee is a restricted-practice state — a nurse practitioner needs a certificate of fitness from the Tennessee Board of Nursing and a collaborating physician named on the prescription (Tenn. Code Ann. §63-7-123). Physicians licensed in Tennessee can prescribe independently. Every Pallas prescription for a Tennessee patient is written by a Tennessee-licensed physician or, where applicable, a nurse practitioner practicing within these requirements.

Several licensed telehealth platforms serve Tennessee residents seeking compounded semaglutide. Before choosing one, verify that its clinicians are licensed in Tennessee, that it dispenses through US-licensed §503A compounding pharmacies, and that it carries LegitScript certification — checkable in LegitScript's public database. Pallas Health serves Tennessee residents, works only with US-licensed pharmacies.

Most Tennessee patients complete Pallas's online intake in about five minutes, and a Tennessee-licensed clinician typically reviews it within 1–2 business days, since Tennessee allows asynchronous-first care with no mandatory video visit. If semaglutide is clinically appropriate, your prescription goes to a US-licensed pharmacy, which ships to any Tennessee address in 2–3 business days after filling — Nashville, Memphis, Knoxville, and Chattanooga typically see the fastest turnaround, with rural counties sometimes taking an extra day. An incomplete intake, a missing ID or photo, or a clinician requesting a follow-up video visit can add time — there is no guaranteed timeline, since review depends on your individual history.

Yes — telehealth access through Pallas is the same across Tennessee, whether you're in Nashville, Memphis, Knoxville, Chattanooga, Clarksville, or a smaller community in the Smoky Mountain foothills of East Tennessee or the West Tennessee Delta. A Tennessee-licensed clinician reviews every intake the same way regardless of ZIP code, and licensed partner pharmacies ship both compounded medications and FDA-approved brands like Wegovy^® to any Tennessee address. Distance from a major metro does not change your eligibility or your care.

Several telehealth providers prescribe tirzepatide to Tennessee residents. Before choosing one, verify that its clinicians hold an active Tennessee medical license, that it works with US-licensed §503A compounding pharmacies (or offers FDA-approved Zepbound^®/Mounjaro^® as the brand-name option), and that it carries LegitScript Healthcare Merchant Certification — checkable in LegitScript's public database. Pallas serves Tennessee residents.

TennCare covers certain GLP-1s for FDA-approved diabetes indications with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service, so TennCare rules do not affect our pricing.

No. Under Tennessee Board of Medical Examiners rules, the prescribing provider must hold an active Tennessee medical license when treating a patient located in Tennessee. Every Pallas clinician who treats Tennessee patients is individually licensed in Tennessee.

In general, GLP-1 medications for weight management are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. Eligibility is always decided by a Tennessee-licensed clinician after reviewing your full intake and medical history, never by an automated quiz — they will tell you directly if a GLP-1 is not appropriate for you.

Brand-name medications — Wegovy^® and Ozempic^® (semaglutide) and Zepbound^® and Mounjaro^® (tirzepatide) — are FDA-approved products from their manufacturers, offered cash-pay. Compounded semaglutide and tirzepatide are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy, when a clinician documents a patient-specific clinical need. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Which option fits you is a clinical decision you make with your Tennessee-licensed provider.

Yes, many patients transfer their care to Pallas. During intake you tell your clinician which medication and dose you take now and how you have tolerated it. Your Tennessee-licensed provider reviews that history and, if appropriate, continues you at a comparable dose or adjusts your titration plan. Do not stop or change a prescription on your own — let your clinician guide any transition.

Most patients use a once-weekly injection with a very fine needle, but a compounded oral semaglutide tablet is available for people who would rather not inject. Both are prescribed only after a clinician confirms they are appropriate for you, and your provider can help you weigh which form fits your routine and goals.

The most common side effects are gastrointestinal — nausea, constipation, diarrhea, or reflux — and they are usually mildest when the dose is raised slowly, which is why clinicians titrate up gradually. GLP-1s are not right for everyone; they are avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2, and during pregnancy. Your Pallas clinician screens for these before prescribing and stays available to help you manage any side effects.

You complete a detailed online intake in under five minutes, sharing your health history, goals, and current medications. A clinician licensed by the Tennessee Board of Medical Examiners reviews it asynchronously in most cases — no live video required — and may follow up by secure message or request labs if your history calls for it. If a GLP-1 is appropriate, your prescription goes to a licensed pharmacy that ships to any Tennessee address, usually within a few business days.

Yes — your plan renews on a regular cadence so your medication arrives before you run out, and your clinician schedules check-ins to monitor your response, adjust your dose, and manage side effects. Pallas care is ongoing, not a one-time script. You can message your care team, change your plan, or cancel anytime from your patient portal — no phone calls or retention hoops.

Compounded semaglutide injection through Pallas is $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Tennessee address, only if a clinician prescribes it, and nothing is charged until then.

Compounded tirzepatide injection through Pallas is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Tennessee address, only if a clinician prescribes it, and nothing is charged until then.

Yes. FDA-approved Wegovy^® (pen or pill), Zepbound^® and Foundayo^™ for chronic weight management — plus Ozempic^® and Mounjaro^® for type 2 diabetes — are available to Tennessee patients cash-pay: the daily Wegovy^® pill and Foundayo^™ are $299 for your first month, then $499 every 4 weeks, and the weekly pens start at $1,069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Tennessee during intake.

Coverage of GLP-1 medications for weight loss through TennCare is limited. TennCare (Tennessee Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service — we do not bill TennCare or private insurance. Pricing is flat and disclosed up front; the cost questions on this page carry current plan terms.

You have two cash-pay paths in Tennessee, and neither requires insurance. One: stay on FDA-approved Wegovy^® or Zepbound^® at flat cash-pay pricing from $1,069/mo. Two: if a clinician licensed in Tennessee determines it is clinically appropriate for you, a compounded semaglutide plan ($139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime.) or compounded tirzepatide plan ($179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime.), prepared per-patient by a US-licensed pharmacy under FDCA §503A. There is no gap in care: start the online intake, tell your clinician what you take now and your current dose, and they factor that history into your treatment plan and starting dose. Our guide to switching GLP-1 telehealth providers on the Pallas blog covers records, timing, and what to expect.

That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound^® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy^® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks. Wegovy^®'s maximum dose is now 7.2 mg weekly, which was not studied in SURMOUNT-5; in the separate STEP UP trial it reached 18.7% average weight loss over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Tennessee weighs your history, goals, and budget to recommend a starting point.

It depends on what you are comparing. Pallas is a cash-pay telehealth service that serves every ZIP code in Tennessee with one all-in plan price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. There is no separate membership fee, and nothing is charged until a clinician prescribes. No video visit is required in Tennessee. Before paying any service, check whether the quoted price includes the medication or is a membership billed on top of it, whether the company is LegitScript-certified, and whether you are charged before a clinician has prescribed.